Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EDP1815 in hospitalized COVID-19 patients
NCT04488575Phase 2Terminated
- Sponsor
- Evelo Biosciences
- Start
- Aug 2020
- Primary completion
- May 2021
- Modality
- Microbiome Therapeutics
- Countries
- 2
01
Overview
A Phase 2 trial of EDP1815 in coronavirus disease 2019 (COVID-19), sponsored by Evelo Biosciences. Started Aug 2020; status: terminated.
02
Drugs
EDP1815
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04488575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04488575.